Hi all, just remember, MSB success will be based on FDA approvals of Ryconcil, and strong phase 3 read outs in back and heart. Plus partnership deals. Large funds are rebalancing their equity holdings and are almost done and will look to allocate into MSB with each milestone. MSB is largely recession proof and revenue is based in USD. Anything covid 19 related is a bonus. there is a reason analysts still have a $5 to $7 MSB rating on this.
keep focusing on fundamentals and hang in there if possible. Demand will sort itself.
Hi all, just remember, MSB success will be based on FDA...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.000(0.00%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.12 | $1.09 | $918.5K | 834.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 34172 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 12789 | 10 |
View Market Depth
| Last trade - 11.14am 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |